Study of Tirzepatide in Healthy Participants
Clinical trial NCT04311424 · COMPLETED
Trial details
- NCT number
- NCT04311424
- Sponsor
- Eli Lilly and Company
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-07-28
- Primary completion
- 2020-10-02
- Enrollment
- 6
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.